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Unexpected fatal neurological deterioration after successful cardio-pulmonary resuscitation and therapeutic hypothermia
Abstract
A 77-year-old woman was admitted to the intensive care unit after successful car- 
diopulmonary resuscitation for out-of-hospital cardiac arrest due to pulseless electrical 
activity. She was treated with mild therapeutic hypothermia to minimise secondary 
anoxic brain damage. 
After a 24 hour period of therapeutic hypothermia with a temperature of 32.5 °C, the 
patient was rewarmed and sedation discontinued. Neurological evaluation after 24 hours 
revealed a maximum Glasgow Coma Score of E4M4Vt with spontaneous breathing. 
However the patient developed a fever reaching 39 °C for several hours that was 
unresponsive to conventional cooling methods. In the subsequent 24 hours the patient 
developed apnoea, hypotension and bradycardia with deterioration of the coma score. 
Diabetes insipidus was confirmed. Cerebral CT was performed which showed diffuse 
brain oedema with herniation and brainstem compression. The patient died within hours. 
Autopsy showed massive brain swelling and tentorial herniation. Hyperthermia possibly 
played a pivotal role in the development of this fatal insult to this vulnerable brain after 
cardiac arrest and therapeutic hypothermia treatment. The acute histopathological 
alterations in the brain, possibly caused by the deleterious effects of fever after cardiac 
arrest in human brain, may be considered a new observation. 
© 2007 Elsevier Ireland Ltd. All rights reserved. 
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Introduction
Important factors determining outcome after out-of-hospital cardiac arrest (OHCA) are 
primary and secondary brain damage. Neurological complications account for two thirds of 
deaths after initial resuscitation of OHCA patients.1 Recently, the use of mild hypothermia 
to lower body metabolism and decrease mechanisms of secondary brain damage has 
been advocated as a standard of care.2 We present a case in which uncontrolled fever; 
even after a 36 hours hypo- and normothermic window, possibly caused secondary brain 
injury and negated the positive effects of mild hypothermia. 
Case report
A 77-year-old woman with a history of aortic valve stenosis and left ventricular hypertrophy 
became increasingly dyspnoeic at home. No immediate life support was started when she 
collapsed. Paramedics arrived at the scene 10 min later and pulseless electrical activity 
was noted. The patient was intubated and resuscitated according to ACLS guidelines. 
Return of spontaneous circulation was noted after a total of 12 min. 
On arrival at the emergency room, she was still comatose (GCS = 1-1-T) with midrange 
dilated pupils unresponsive to light. On ICU admission, her vitals signs were as follows: 
temperature 33.9 °C, heart rate 65 beats/min, blood pressure 120/60 mmHg, and 
intubated with controlled mechanical ventilation. The initial arterial blood gas showed 
pH 7.29 (7.37-7.45), pCO2 4.4 kPa (4.5-6.0 kPa), pO2 14.2 kPa (9.5-13.0 kPa), HCO3 
15.6 mmol/l (22-26 mmol/l), BE -9.4 mmol/l (-2.0 to +2.0 mmol/l), SaO2 97% (92-99%). 
Laboratory examination revealed an initial lactate of 14.8 mmol/l (0.5-1.7 mmol/l). 
Troponin-I levels were only mildly elevated: 1.8 mcg/l (0-0.48 mcg/l). 
Cardiac ultrasound revealed severe left ventricular hypertrophy with reduced LV function 
and aortic valve stenosis with a gradient of 50-70 mmHg. 
Mild therapeutic hypothermia was initiated and the patient was sedated and actively 
cooled to a core temperature of 32.5 °C. Target temperature was reached within 2 
hours of admission. Cooling was performed with a 2 liter cold saline infusion (4 °C) in 
combination with an external cooling mattress. 
Hypothermia was maintained for 24 hours. During this period, no significant 
haemodynamic instability occurred. Her mean arterial pressure was above 70 mmHg at 
all times with low doses of norepinephrine (noradrenaline) (dose range up to 0.05 mcg/
kg/min) and intravenous fluids with a target central venous pressure between 8 and 10 
mmHg. Venous mixed oxygen saturation (ScvO2) was 89% at the start of cooling. After 24 
hours the patient was slowly rewarmed at a controlled rate of 0.3 °C/h until she reached 
a core body temperature of 36 °C. Sedation was stopped at that time. Over the next day, 
the neurological condition of the patient improved. Spontaneous breathing started and 
GCS improved to E4M4Vt. However, during the following 24 hours, the patient developed 
high fever, reaching body temperature of a maximum of 39 °C. All devices used to induce 
hypothermia were unavailable at that moment. Fever was treated with paracetamol and 
intravenous cefotaxime was started for suspected pulmonary infection. However, she 
remained hyperthermic for 34 hours. 
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The patient had episodes of bradypnoea which ultimately required renewed controlled 
mechanical ventilation. Subsequently, she developed hypertension, followed by 
hypotension and relative bradycardia. Pupils were fixed and dilated and a deterioration 
of GCS to E1M1Vt was noted. She developed polyuria (> 300 ml urine/h) and diabetes 
insipidus was diagnosed subsequently. 
A cerebral CT-scan was performed showing massive and diffuse cerebral oedema. 
Complete compression of the fourth ventricle and supratentorial herniation was con- 
firmed. Clinical brainstem death was reported after a neurological examination. The 
patient died in a matter of hours. 
Post-mortem examination of the brain confirmed acute massive brain oedema with 
ischaemic changes, unlikely caused by the initial cardiac arrest. Furthermore, signs of 
congestive heart failure such as pulmonary oedema and bilateral pleural effusions were 
noted. 
Discussion
Sudden cardiac death (SCD) is a term used to describe cardiac arrest with cessation of 
cardiac functions regardless of the mechanism. Most common causes are ventricular 
fibrillation (VF), pulseless ventricular tachycardia (PVT), pulseless electrical activity (PEA) 
or asystole. PEA accounts for almost 25% of all cases of SCD.3 Resuscitation techniques 
and guidelines have improved over the last decade which resulted in improved survival 
after cardiac arrest.2,3 However, some survivors become vegetative and die from 
complications. 
The development of mild therapeutic hypothermia as a treatment strategy has 
demonstrated the potential to improve neurological outcome.4,5 In 2002, two major 
studies were published that compared normothermia and therapeutic hypothermia 
in out-of-hospital cardiac arrest patients who were comatose on admission. One large 
European trial which targeted a temperature of 32-34 °C showed a relative risk of 1.4 
in favour of the hypothermia group in terms of favourable neurological outcome (able to 
live independently and work at least part-time). The number needed to treat was six to 
achieve one additional surviving patient with good neurological function.2 
The Australian study although smaller showed similar results; a relative risk reduction of 
1.85 in favour of the hypothermia group.5 Although evidence for other initial rhythms than 
VF in case of SCD is scarce, some series and case reports do suggest positive effects in 
non-VF cases.6,7 
We present a case of a patient with PEA and aortic valve stenosis, who was treated with 
mild hypothermia according to our local cooling protocol for patients for out-of-hospital 
cardiac arrest patients. Apart from the evidence supporting hypothermia treatment as 
brain protection there is also overwhelming evidence suggesting that hyperthermia may 
be deleterious and can increase ischaemic damage to the brain following a primary 
insult. 
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Animal experiments show that even delayed hyperthermia (up to 24 h) can result in very 
enhanced neurological damage after ischemic insults.8,9 
Prospective trials in stroke victims have also shown that fever (T > 37.9 °C) is an 
independent predictor of poor outcome (odds ratio 3.4).10 Another trial in a similar 
patient group showed an increase of 2.2-fold (95% confidence interval, 1.4-3.5) for every 
1 °C elevation of body temperature.11 To add to that evidence in cardiac arrest in 2001 
results were published on patients with a favourable neurological outcome that showed 
a lower peak temperature (37.7 °C versus 38.3 °C; P = 0.001).12 The risk of unfavourable 
neurological outcome increased 2.2-fold per 1 °C elevation of body temperature. 
This study did not focus on the causes of fever; however there were no statistical 
differences in markers of infection (white blood cell level, fibrinogen levels, C-reactive 
protein) or infiltrative disorders on chest X-ray. 
Higher temperatures were also shown to be associated with a higher incidence of brain 
death in another study of pyrexia following cardiac arrest.13 Comparing the weighted 
mean temperature (the area under the curve > 37 °C, divided by the time it was elevated) 
patients with a favourable neurological outcome had lower temperatures than in patients 
with an unfavourable neurological outcome (P = 0.002). 
Although it cannot be excluded that the rise in body temperature resulted from brain 
damage rather than that it may have caused it, there is ample evidence to conclude that 
pyrexia is detrimental in neurological injury. It has been shown to increase the release of 
excitatory neurotransmitters.14,15 Free radical production has been shown to increase 4-5-
fold in hyperthermic ischaemia compared to a 2-3-fold increase in normothermia.16,17 In 
addition, adenosine triphosphate depletion and less complete recovery of the levels may 
occur during hyperthermia.18 Furthermore, calpain activation and spectrin proteolysis 
in cortical pyramidal neurons is enhanced during hyperthermia and associated with 
morphological evidence of irreversible neuronal injury.19 
It is important to consider that while most temperatures are measured rectally to 
assess systemic temperature, brain temperatures following an insult are often higher. 
During direct measurement of brain temperature, brain temperatures exceeded body 
temperature in 90% of cases with the maximal gradient being 2.3 °C.20 Other studies 
have shown focal differences in brain temperature after focal insults.21 
While the clinical applications of these findings may not be completely clear, one can 
hypothesize that when measuring modest systemic temperature elevations in patients 
with vulnerable brains due to ischaemia and reperfusion, brain temperature may already 
be at a dangerous level. 
Experimental data have shown that even days after cardiac arrest some of the pathological 
processes in the brain may still persist stressing the importance of avoiding temperature 
rises in this period as fever can fuel this deleterious effects.22 
Based on pathological post-mortem examinations, this case in our view suggests that 
fever may have caused late and ultimately fatal neurological deterioration after successful 
cardio-pulmonary resuscitation and therapeutic hypothermia.
 
37
Unexpected fatal neurological deterioration after successful cardio-pulmonary resuscitation and therapeutic hypothermia
Conclusions
Fever is a risk factor for poor neurological outcome after cardiac arrest. How long this 
vulnerability of the brain lasts and the risk for neurological deterioration persists is not 
known. However our observations suggest that hyperthermia should be aggressively 
treated for several days after return to normothermia. In our ICU we try to control 
temperature after OHCA in the normothermic range up to 72 hours after the cessation of 
mild hypothermia in order to minimise damage by secondary mechanisms. Beware of the 
comatose patient with fever after out-of-hospital cardiac arrest even after therapeutic 
hypothermia! 
Conflict of interest
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